microdose glp-1 menopause THE PCCA BLOG Microdosing GLP‑1 in Menopause &

Under the best circumstances, deciding to take a GLP-1 drug is a complex medical decision and patients need regular monitoring, McGowan, from True You Weight Loss, said

During ongoing weight loss, high-precision 3D body scanning may help track body-composition trends, while metabolic testing and analysis may add information about resting energy needs as weight changes

Boehringer Ingelheim Recent Developments In April 2026 , Eli Lilly's Foundayo (orforglipron) received FDA approval for adults with obesity or overweight-related health issues

counsel patients on pacing meals, eating slowly, and avoiding high-fat trigger foods

They should not be used during pregnancy or while breastfeeding